← Leaderboards
Stuart Duncan Ibsen
Oregon Health & Science University
$1,853,683
Attributed
$1,853,683
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $471.7K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,853,683 · 1
By mechanism
R37$1,853,683 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jay A Nelson$38,488,581
- Cynthia T McEvoy$23,252,466
- Gregory S. Yochum$1,994,895
- Donald F. Conrad$17,126,133
- Joel T Nigg$26,089,587
Others in their field
Other Rising Stars on “Dependence”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- John Alam · Eip Pharma, Inc.$10,411,018
- Meera Sampath · Suny At Binghamton$9,956,488
- George Gaitanaris · Omeros Corporation$6,689,019
Research focus
DependenceBenignCytolysisBiomarker PanelBlindedBloodBlood-Based BiomarkerAcute PancreatitisBlood Plasma VolumeBlood TestsCa-19-9 AntigenCancer DetectionCancer PatientCancer TypeCandidate MarkerCategoriesBiological MarkersClinicClinical DevelopmentCohort StudiesCollectionCostCystDetection
Grant awards (4)
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers$471,675
R37 · FY2025 · CA · contact PI
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers$448,091
R37 · FY2024 · CA · contact PI
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers$462,242
R37 · FY2023 · CA · contact PI
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers$471,675
R37 · FY2022 · CA · contact PI